Hagens Berman Alerts Investors in Cellular Biomedicine Group, Inc. (NASDAQ: CBMG) of June 22nd Lead Plaintiff Deadline
May 07, 2015 08:30 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 7, 2015 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, advises investors of the June 22, 2015 lead plaintiff deadline in a class action...